4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-024228
Chief Financial Officer sold 2,641 shares at $1.89 ($4,991)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mostafa Adam S. Chief Financial Officer | 2023-06-30 | Sale | −2,641 | $1.89 | $4,991 | 80,221 | D |
| Open-market sales · 2,641 sh · avg $1.89 · $4,991 | |||||||
Loading xslF345X04/wk-form4_1688587453.xml…